Ruypeptide Biotechnology Co., Ltd.** is expanding its international presence by strengthening its biotechnology research capabilities, manufacturing capacity, and global customer support as demand for ...

Biopharmaceutical innovation has traditionally been difficult to capture through market exposures. This article explores how ...

CPIC 2026 opens in Shanghai on July 22. [Photo provided to chinadaily.com.cn] Global pharmaceutical leaders convened in ...

Global biotech firms are increasingly being drawn to Hong Kong for its growing investor base and proximity to Chinese ...

New initiative under NSG Bio Tomorrow will support promising startups developing next-generation approaches in respiratory and neonatal care ...

Priyanka Aggarwal, India and South East Asia Leader, Healthcare Practice at Boston Consulting Group (BCG), said patent ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the 'Company' or 'Jyong Biotech'), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived therapeutics ...

Despite its status as the “pharmacy of the world,” India’s deep life sciences roots have traditionally been based in ...

India's NITI Aayog has unveiled a blueprint for a $691 billion bioeconomy by 2035, proposing a ₹50,000-crore growth fund, six ...

StabilLux Biosciences has expanded by opening a new microscopy and cell culture laboratory, as the firm gets ready launch its ...

One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and ...

With its focus on small-cap companies and exposure to China, The Biotech Growth Trust (BIOG) is one such example. Over the past year, the trust’s total shareholder return was 105 per cent – double the ...